The University Hospital Center of São João, or simply São João Hospital, is the main hospital of the city of Porto, Portugal, and also the Porto metropolitan area and the North of Portugal. It's also a medical school, the Faculty of Medicine of the University of Porto.

During the past decade, Hospital de São João conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 10 clinical trials were completed, i.e. on average, 52.6% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 7 clinical trials were completed. i.e. 70% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de São João" #1 sponsor was "Abbott Medical Devices" with 4 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Celgene" with 3 trials sponsored, "Gilead Sciences" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de São João" #1 collaborator was "University Hospital Regensburg" with 2 trials as a collaborator, "A.O.U. Città della Salute e della Scienza - Molinette Hospital" with 1 trials as a collaborator, "Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia" with 1 trials as a collaborator, "Bambino Gesù Hospital and Research Institute" with 1 trials as a collaborator and "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator. Other collaborators include 95 different institutions and companies that were collaborators in the rest 105 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de São João" are "HIV Infections" (3 trials), "Autoimmune Pulmonary Alveolar Proteinosis" (2 trials), "Coronary Arteriosclerosis" (2 trials), "Cystic Fibrosis" (2 trials) and "HIV-1" (2 trials). Many other conditions were trialed in "Hospital de São João" in a lesser frequency.

Most popular intervention types in "Hospital de São João" are "Drug" (35 trials), "Device" (12 trials), "Other" (3 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Degarelix" (2 trials), "ELX/TEZ/IVA" (2 trials), "Gemcitabine" (2 trials) and "IVA" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de São João" are 52 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital de São João". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Hospital de São João, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de São João, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 6 trials that are defined as “Not Applicable".